Logo-bi
Original Research
Ibrahim Torktaz, Mohaddeseh Behjati*, Sareh Arjmand
Bioimpacts. 2013;3(4): 177-183. doi: 10.5681/bi.2013.022
PMCID: PMC3892737     PMID: 24455481     Scopus ID: 84893381729    
PDF
XML
Cited By:
Original Research
Ibrahim Torktaz*, Faezeh Mohamadhashem, Abolghasem Esmaeili, Mohaddeseh Behjati, Sara Sharifzadeh
Bioimpacts. 2013;3(3): 141-144. doi: 10.5681/bi.2013.026
PMCID: PMC3786797     PMID: 24163807     Scopus ID: 84887341373    
PDF
XML
Cited By:
Original Research
Samaneh Rashtbari, Gholamreza Dehghan*, Reza Yekta, Abolghasem Jouyban
Bioimpacts. 2017;7(3): 147-153. doi: 10.15171/bi.2017.18
PMCID: PMC5684506     PMID: 29159142     Scopus ID: 85032025147    
Original Research
Hassan Rasouli, Amir Hossein Norooznezhad, Tahereh Rashidi, Zohreh Hoseinkhani, Azadeh Mahnam, Mitra Tarlan, Narges Moasefi, Ali Mostafaei*, Kamran Mansouri*
Bioimpacts. 2018;8(4): 281-294. doi: 10.15171/bi.2018.31
PMCID: PMC6209826     PMID: 30397583     Scopus ID: 85056111430    
Original Research
Mohammad Reza Asgharzadeh, Mohammad M. Pourseif, Jaleh Barar ORCID, Morteza Eskandani, Mojtaba Jafari Niya, Mohammad Reza Mashayekhi, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(3): 145-159. doi: 10.15171/bi.2019.19
PMCID: PMC6726749     PMID: 31508330     Scopus ID: 85071154393    
Increased expression of TSGA10 associated with the reduced metastasis in the MDA-MB-231 cells. TSGA10 showed interaction with HIF-1α with high affinity. TSGA10 expression is altered under the hypoxia, indicating its potential as a bio-target for cancer therapy.
Original Research
Mohammad Mostafa Pourseif, Mitra Yousefpour*, Mohammad Aminianfar, Gholamali Moghaddam, Ahmad Nematollahi ORCID
Bioimpacts. 2019;9(3): 131-144. doi: 10.15171/bi.2019.18
PMCID: PMC6726745     PMID: 31508329     Scopus ID: 85071191509    
The minigene vaccine construct is designed based on the B and T cell epitopes of E. granulosus enolase protein, and ligands for TLR-2 and TLR-4. The minigene vaccine showed stable properties for proper binding with the Toll-like receptors.
Original Research
Babatomiwa Kikiowo* ORCID, Adewale Joseph Ogunleye, Olumide Kayode Inyang, Niyi Samuel Adelakun, Olaposi Idowu Omotuyi, Damilohun Samuel Metibemu, Temitope Israel David, Oluwatoyin Olajide Oludoyi, Taiwo Tolulope Ijatuyi
Bioimpacts. 2020;10(4): 227-234. doi: 10.34172/bi.2020.29
PMCID: PMC7502905     PMID: 32983938     Scopus ID: 85092042568    
Flavones scaffold interacts with the molybdenum atomic domain and some other amino acid residues of XO that are essential for enzymatic action and hence blocked catalytic activities.
Original Research
G Divyashri* ORCID, T P Krishna Murthy, Subramaniam Sundareshan, Pavan Kamath, Manikanta Murahari*, G R Saraswathy, Bindu Sadanandan
BioImpacts. 2021;11(2): 119-127. doi: 10.34172/bi.2021.19
PMCID: PMC8022237     PMID: 33842282     Scopus ID: 85106557158    
Novel inhibitors from Mango ginger were identified against five drug targets of H. pylori. In silico potential of Mango ginger compound, gentisic acid with the drug target, shikimate kinase was evaluated. Results were found promising without any limitations.
Original Research
Aditya Rao Rao Shimoga Janakirama* ORCID, Suma Mathad Shivayogi, Jamuna Kolkar Satyanarayana, Ramesh Chapeyil Kumaran
BioImpacts. 2021;11(3): 187-197. doi: 10.34172/bi.2021.09
PMCID: PMC8314033     PMID: 34336607     Scopus ID: 85106345298    
From Phytochemicals to Biologically active natural product drugs.
Original Research
Khalil EL Khatabi ORCID, Ilham Aanouz, Marwa Alaqarbeh, Mohammed Aziz Ajana, Tahar Lakhlifi, Mohammed Bouachrine* ORCID
BioImpacts. 2022;12(2): 107-113. doi: 10.34172/bi.2021.22143
PMCID: PMC8905587     PMID: 35411302     Scopus ID: 85127183196    
Molecular docking was performed to explore the binding affinity of the 12 selected molecules in the target enzyme and then evaluated for in silico ADMET properties. The best hits were subjected to molecular dynamics simulation.
Original Research
Raja Rajeswari Rajeshkumar ORCID, Banoth Karan Kumar ORCID, Pavadai Parasuraman ORCID, Theivendren Panneerselvam ORCID, Krishnan Sundar ORCID, Damodar Nayak Ammunje ORCID, Sureshbabu Ram Kumar Pandian ORCID, Sankaranarayanan Murugesan ORCID, Shanmugampillai Jeyarajaguru Kabilan ORCID, Selvaraj Kunjiappan*
BioImpacts. 2022;12(6): 487-499. doi: 10.34172/bi.2022.24113
PMCID: PMC9809135     PMID: 36644543     Scopus ID: 85143350606    
The bioactive compounds from Cynodon dactylon potentially degrade the α-Syn aggregation in the brain through in silico molecular docking investigations. A molecular dynamics simulation confirms the stability of the α-Syn-ligand complex.
Original Article
Ali Zeiz ORCID, Ranin Kawtharani, Mirvat Elmasri, Ghada Khawaja, Eva Hamade, Aida Habib, Abeer J. Ayoub, Mohamed Abarbri, Mohammad H. El-Dakdouki* ORCID
Bioimpacts. 2024;14(2): 27688. doi: 10.34172/bi.2023.27688
PDF
XML
Cited By:
Original Article
Muammar Fawwaz* ORCID, Kenji Mishiro* ORCID, Arwansyah Arwansyah, Ryuichi Nishii, Kazuma Ogawa* ORCID
Bioimpacts. 2024;14(1): 27774. doi: 10.34172/bi.2023.27774
PMCID: PMC10844591     PMID: 38327635    
Original Article
Navid Mohammadjani ORCID, Sahand Karimi, Musa Moetasam Zorab ORCID, Morahem Ashengroph* ORCID, Mehran Alavi* ORCID
Bioimpacts. 2024;14(2): 27778. doi: 10.34172/bi.2023.27778
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge